Skip to main content

Countries of our scientists:AustraliaTurcjaNiemcyBrazyliaEgiptHiszpaniaIndieIranPeruWietnamPolskaAustraliaTurcjaNiemcyBrazyliaEgiptHiszpaniaIndieIranPeruWietnamPolskaAustraliaTurcjaNiemcyBrazyliaEgiptHiszpaniaIndieIranPeruWietnamPolska


This week (October 17 – 19) Professors Roberto Para Saldivar and Elda Melchor-Martinez from Technológico de Monterrey, Mexico, who visited our University, delivered lectures at ICRI-BioM and had extensive meetings with leaders of the research groups that seem to be on an excellent way to scientific collaboration and faculty exchange, and students from Monterrey Tech practices at the Center. We eagerly look forward to the crystallization of these plans.


The group leaders and post-doctoral researchers of ICRI-BioM participated in the 4th Interdisciplinary FNP conference held in Warsaw during 6-7 October 2022.


On June 24-25, 2022, a meeting between the management of ICRI-BioM and TUL's authorities took place in the guest house of TUL in Konopnica. Discussion started with presentations of research and teaching potentials of the Center, and was followed by discussion on possible ways of collaboration, joint teaching activities at all levels, as well as on the visibility and sustainability of the Center.

Main research areas

Molecular biotechnology

In particular, new biological materials, new biocatalysts, and new regulatory molecules.

New materials

In particular, new bio-compatible polymers and bioconjugates.

Applied computational technologies

In particular, computer simulations and computational tools for the prediction of properties, structure, and dynamics of molecular and macromolecular systems.


The Project is carried out within the International Research Agendas PLUS programme of the Foundation for Polish Science, co-financed by The European Union under the European Regional Development Found,with the budget of: PLN 31 000 000.



Max Planck Institute

Strategic Partner
Industrial Partners

SiA Pietrucha Sp. z o.o.

Grupa Maspex sp. z o.o sp. k

Adamed Pharma S.A.

Copyright © 2021 - All Rights Reserved